Purpose: Source strength (S k ), sizes of vaginal cylinder applicators (VCA), number of dwell positions (DPs), and the prescribed dose (D) are basic parameters in brachytherapy (BT) treatment planning contributing to total dwell time (TDT). This study was aimed at assessing the relationships between the specified variables in an attempt to verify the TDT in high-dose-rate (HDR) vaginal cylinder applications. 
(HDR) techniques. 1 High-dose-rate brachytherapy has, however, become the major practice across the world, particularly in the developed nations. 2 Its choice as a substitute for the LDR technique is due to the related advantages. These include shortened treatment time, outpatient-based treatment, and improved patient comfort. In addition, the use of the HDR vaginal cylinders is simple and offers better placement of the applicators in relation to the desired anatomic structures than the tandem-ring and tandem-ovoid combinations. There is also a better dosimetric control for the small and high-intensity source that moves through the cylinder at 5-mm intervals. 3 The HDR technique, however, requires a stricter level of quality assurance (QA) to ensure adequate safety in its operations including the computerized treatment planning. Each step in the integrated process of RT needs quality control and quality assurance to prevent a number of errors and to give high confidence that patients will receive the prescribed treatment correctly. [4] [5] [6] One vital component of the QA is the independent checks of total dwell times for brachytherapy dose delivery by manual calcula- 
| MATERIAL AND METHODS
In this study, we acquired dosimetric data on Cobalt-60 airkerma strength, doses to the prescription points, numbers of dwell positions, and the TDT related to the initial ICBT applications of the subjects considered. The first and the second parameters were reexpressed in cGy.cm 2 /min and cGy, respectively, in order for TDTs to be obtained directly in minutes which is realistic for HDR treatments. EViews (version 9) statistical software (Canada) was used on the three sets of data (based on applicator diameters) to perform a regression analysis in two phases. Firstly, the three quantities highlighted in eq. (1) were modeled to verify their relationship.
Regression analysis of the treatment planning data involving three parameters yielded a relationship given as:
This is a resemblance of eq. (1) in literature.
By comparing the resulting eq. (2) with the previous, a mathematical expression (eq. 3) for the treatment time factor was obtained.
While b 0 is the intercept, b 1 being the slope represents the treatment time factor which can be evaluated as:
The values of the parameter K were therefore evaluated for the three sizes of the VCA. The other stage involved the inclusion of the number of the DPs as an additional parameter in the statistical analysis.
Further regression analysis incorporating the treatment length factor (number of DPs) resulted in a mathematical relationship as follows:
The two models developed were used to generate predicted dose delivery times which were compared with the corresponding TPS values.
| RESULTS
The descriptive of brachytherapy plan parameters and the corresponding P-values as determined by the analysis of variance are presented in Table 2 .
The values of the coefficients b 0 and b 1 for the respective diameters of the applicators are given in Table 3 . In Table 4 , the resulting K values evaluated using eq. (3) are presented.
The intercepts and the coefficients of the variables related to eq. (4) for the three cylinder sizes are therefore presented in Table 5 .
Regression analyses in both cases were at a level of significance of 0.01.
In [10] [11] [12] The situation is the same at our institution following the trend obtained in Table 1 Table 1 .
The minimum values of the air-kerma strength across the three applicator sizes are quite comparable. The maximum S k related to the 30 mm VCA which was lower than for other patient groups only indicated that some patients were treated with the applicator on later dates. Treatment lengths along the applicator within the study duration ranged from 2 to 10 cm (4-20 DPs ] within the study period of 5 years.
Results of ANOVA (Table 2) show there are no statistically significant differences in the number of dwell positions (P = 0.371) and the prescribed doses per fraction (P = 0.023). This is very obvious as the range of DPs and doses used in treatment planning was very similar across the VCA sizes. However, the means of S k and TDTs related to the various applicators differ significantly (P = 0.000). This should be the case as different applicators were used for ICBT at varying times, therefore necessitating appreciable differences in S k at the treatment dates. Consequently, the dose delivery time would differ considerably considering the feasible changes in source strength and the varying dimensions of the intravaginal applicator. Table 3 presents the combined outputs of the regression analysis involving three variables. We recall that a treatment time factor, K, was earlier identified in the study of Mayo and Ulin. 8 According to the authors, the cylinder radius, prescription radius, and the active lengths prescribed to 5 mm depth and to the surface of the VCA were both given considerations in the determination of K. This study considered the sizes of the VCA separately in the process of evaluating K for dose prescriptions to 5 mm away from the cylinder's surface only. The coefficient b 1 in Table 3 which is representative of K showed a significant dependence on the cylinder radius which normally determines the prescription radius for a given treatment plan.
It is therefore a precursor to the pattern of the evaluated treatment time factors, K, presented in Table 4 , showing variability with treatment lengths along the different applicator sizes as illustrated in Fig. 2 . In general, it was found to have increased with the number of dwell positions activated for treatment. Moreover, the factor becomes more significant as the applicator becomes bigger in size.
This could be attributed to the fact that the proximity of the dose prescription points to the source positions at the center of the intravaginal applicator (Fig. 1) will vary with the cylinder size. To this effect, the TDT to deliver a given dose would be influenced accordingly. The above trends are comparable to the outcomes of the study of Mayo and Ulin involving same sizes of the VCA. 8 However, Co-60 at our institution is premised on economic factor. An average of 20 source replacements for Ir-192 is needed for a corresponding single-source replacement of a Co-60 source. An iridium source replacement would require an average cost of about 15,000 USD, culminating in a total of about 300,000 USD for a 60-month period.
However, the cost of a Co-60 source change during the same period (after its half-life of 5 years) is about 34,000 USD.
14 Table 5 presenting a P-value of 0.000 shows the combined rele- The verification program which requires an input of the S k and the related parameters is spreadsheet based and can be executed in less than a minute. Our institutional study has also helped to gain insights on how the total dwell time for cylinder applications would vary with the treatment parameters in order to be properly guided in HDR brachytherapy administration. This knowledge is also needful when certain changes are made to BT parameters from one treatment fraction to another. As most gynecological cancers present late in Nigeria, there is a great strain on the country's radiotherapy facilities. 10 A judicious use of the HDR brachytherapy equipment which is grossly inadequate in Nigeria is therefore of the essence. 
| CONCLUSIONS

